US$ 29.82
whats better than tirzepatide vs. Semaglutide: Key Differences & Benefits RETA Is More Powerful... But
Description
Retatrutide (LY3437943) is a first-in-class triple-receptor agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon

The available data on these patients is limited but consistent with the pharmacological predictions

These answers are based on how the drug works

The honest answer: any shedding is usually from rapid weight loss, not the medication itself, and it is temporary
For those using compounded tirzepatide, several precautions apply
